Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TESC antisense RNA 1 (TESC-AS1) is a long non-coding RNA (lncRNA) gene located on chromosome 12 and belongs to the antisense RNA class[1][5]. Like other antisense lncRNAs, TESC-AS1 is thought to regulate the expression of neighboring or related genes via RNA-RNA or RNA-chromatin interactions[2][3]. Antisense RNAs overall play significant roles in gene expression control, either by repressing or activating transcription, often through epigenetic regulatory mechanisms. While many antisense lncRNAs are increasingly recognized as important for normal cell regulation and disease processes such as cancer, TESC-AS1 itself does not currently have a well-established direct disease association or therapeutic targeting, and no drugs specifically act on this molecule[1][5][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TESC antisense RNA 1 (head to head) (TESC-AS1).